Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Farinha
Foxp1 Expression Is Inversely Correlated With Ezh2 Mutation Status and Predicts Poor Failure-Free Survival in Follicular Lymphoma Treated With Rituximab and Chemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
How to Break Access Control in a Controlled Manner
Related publications
Decreased LIPF Expression Is Correlated With DGKA and Predicts Poor Outcome of Gastric Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
M7‐FLIPI Is Not Prognostic in Follicular Lymphoma Patients With First‐line Rituximab Chemo‐free Therapy
British Journal of Haematology
Hematology
Human Germinal Center-Associated Lymphoma Protein Expression Is Associated With Improved Failure-Free Survival in Brazilian Patients With Classical Hodgkin Lymphoma
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Characteristics and Outcomes of Patients With Relapsed Follicular Lymphoma Following Retreatment With Second-Line Rituximab-Containing Chemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype
Frontiers in Oncology
Cancer Research
Oncology
Pretreatment Immune Status Correlates With Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients
Cancer immunology research
Cancer Research
Immunology
Association of MDM2 Expression With Shorter Progression-Free Survival and Overall Survival in Patients With Advanced Pancreatic Cancer Treated With Gemcitabine-Based Chemotherapy
PLoS ONE
Multidisciplinary
Mps1 Is Associated With the BRAFV600E Mutation and Predicts Poor Outcome in Patients With Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma
British Journal of Haematology
Hematology
